May 8 |
Vanda Pharmaceuticals GAAP EPS of -$0.07, revenue of $47.46M
|
May 8 |
Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
|
May 7 |
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
|
May 7 |
Vanda Pharmaceuticals up 15% as Future Pak sweetens bid
|
May 7 |
UPDATE 2-Future Pak sweetens take-private offer for Vanda Pharmaceuticals
|
Apr 30 |
Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
|
Apr 25 |
UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer
|
Apr 25 |
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
|
Apr 24 |
Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
|
Apr 24 |
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
|